161 filings
ARS
2023 FY
GH
Guardant Health Inc
25 Apr 24
Annual report to shareholders
4:48pm
DEFA14A
GH
Guardant Health Inc
25 Apr 24
Additional proxy soliciting materials
4:43pm
DEF 14A
GH
Guardant Health Inc
Definitive proxy
25 Apr 24
4:21pm
8-K
GH
Guardant Health Inc
22 Mar 24
Departure of Directors or Certain Officers
5:10pm
S-8
GH
Guardant Health Inc
23 Feb 24
Registration of securities for employees
4:10pm
8-K
lmmyw zy2xxqx6ya4yr
22 Feb 24
Guardant Health Reports Fourth Quarter and Full Year 2023 Financial Results and Provides 2024 Outlook
4:10pm
8-K
cjj75mnlazs mr4uw8z
1 Feb 24
Departure of Directors or Certain Officers
4:20pm
8-K
tcy ogyiuz
8 Jan 24
Guardant Health Announces Preliminary Fourth Quarter and Full Year 2023 Results
4:17pm
8-K
qv874o8o
21 Dec 23
Guardant Health Announces $90.7 Million Registered Direct Offering with Baillie Gifford
4:07pm
424B5
m2jdge4itu7
21 Dec 23
Prospectus supplement for primary offering
9:16am
8-K
nhyzze2yt8a8q8guk
19 Dec 23
Guardant Health Announces Tentative Date of FDA Advisory Panel Review of Shield™ Blood Test
5:20pm
8-K
n2d3lvaisbq4fzcvliwc
15 Nov 23
Other Events
6:04am
8-K
eu21nxmm31zc9cd29p8
6 Nov 23
Guardant Health Reports Third Quarter 2023 Financial Results and Increases Revenue Guidance
4:10pm
8-K
g3utf
3 Nov 23
Departure of Directors or Certain Officers
5:10pm
8-K
us6rxc2
7 Sep 23
Regulation FD Disclosure
7:30am
S-8
ejx4cbc4y1rj jkn
10 Aug 23
Registration of securities for employees
4:06pm
8-K
3t6krx zv4iy548lv
3 Aug 23
Guardant Health Reports Second Quarter 2023 Financial Results and Increases Revenue Guidance
4:14pm